Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

230 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Short-course rifampin and pyrazinamide compared with isoniazid for latent tuberculosis infection: a multicenter clinical trial.
Jasmer RM, Saukkonen JJ, Blumberg HM, Daley CL, Bernardo J, Vittinghoff E, King MD, Kawamura LM, Hopewell PC; Short-Course Rifampin and Pyrazinamide for Tuberculosis Infection (SCRIPT) Study Investigators. Jasmer RM, et al. Among authors: bernardo j. Ann Intern Med. 2002 Oct 15;137(8):640-7. doi: 10.7326/0003-4819-137-8-200210150-00007. Ann Intern Med. 2002. PMID: 12379063 Clinical Trial.
Rifampin preventive therapy for tuberculosis in Boston's homeless.
Polesky A, Farber HW, Gottlieb DJ, Park H, Levinson S, O'Connell JJ, McInnis B, Nieves RL, Bernardo J. Polesky A, et al. Among authors: bernardo j. Am J Respir Crit Care Med. 1996 Nov;154(5):1473-7. doi: 10.1164/ajrccm.154.5.8912767. Am J Respir Crit Care Med. 1996. PMID: 8912767
Substitution of moxifloxacin for isoniazid during intensive phase treatment of pulmonary tuberculosis.
Dorman SE, Johnson JL, Goldberg S, Muzanye G, Padayatchi N, Bozeman L, Heilig CM, Bernardo J, Choudhri S, Grosset JH, Guy E, Guyadeen P, Leus MC, Maltas G, Menzies D, Nuermberger EL, Villarino M, Vernon A, Chaisson RE; Tuberculosis Trials Consortium. Dorman SE, et al. Among authors: bernardo j. Am J Respir Crit Care Med. 2009 Aug 1;180(3):273-80. doi: 10.1164/rccm.200901-0078OC. Epub 2009 Apr 30. Am J Respir Crit Care Med. 2009. PMID: 19406981 Clinical Trial.
Short-course rifampin and pyrazinamide compared with isoniazid for latent tuberculosis infection: a cost-effectiveness analysis based on a multicenter clinical trial.
Jasmer RM, Snyder DC, Saukkonen JJ, Hopewell PC, Bernardo J, King MD, Kawamura LM, Daley CL; Short-Course Rifampin and Pyrazinamide for Tuberculosis Infection Study Investigators. Jasmer RM, et al. Among authors: bernardo j. Clin Infect Dis. 2004 Feb 1;38(3):363-9. doi: 10.1086/380966. Epub 2004 Jan 13. Clin Infect Dis. 2004. PMID: 14727206 Clinical Trial.
An official ATS statement: hepatotoxicity of antituberculosis therapy.
Saukkonen JJ, Cohn DL, Jasmer RM, Schenker S, Jereb JA, Nolan CM, Peloquin CA, Gordin FM, Nunes D, Strader DB, Bernardo J, Venkataramanan R, Sterling TR; ATS (American Thoracic Society) Hepatotoxicity of Antituberculosis Therapy Subcommittee. Saukkonen JJ, et al. Among authors: bernardo j. Am J Respir Crit Care Med. 2006 Oct 15;174(8):935-52. doi: 10.1164/rccm.200510-1666ST. Am J Respir Crit Care Med. 2006. PMID: 17021358 Review.
Lymphocyte recruitment to the lung.
Berman JS, Beer DJ, Theodore AC, Kornfeld H, Bernardo J, Center DM. Berman JS, et al. Among authors: bernardo j. Am Rev Respir Dis. 1990 Jul;142(1):238-57. doi: 10.1164/ajrccm/142.1.238. Am Rev Respir Dis. 1990. PMID: 2195933 Review.
Cytokine binding to CD4+ inflammatory cells: implications for asthma.
Center DM, Kornfeld H, Wu MJ, Falvo M, Theodore AC, Bernardo J, Berman JS, Cruikshank WW, Djukanovic R, Teran L, et al. Center DM, et al. Among authors: bernardo j. Am J Respir Crit Care Med. 1994 Nov;150(5 Pt 2):S59-62. doi: 10.1164/ajrccm/150.5_Pt_2.S59. Am J Respir Crit Care Med. 1994. PMID: 7952594 Review.
Tuberculosis prevention in college students.
Lerman SJ, Bernardo J, Daly JS, Husson R. Lerman SJ, et al. Among authors: bernardo j. J Am Coll Health. 2004 Sep-Oct;53(2):53-8. doi: 10.3200/JACH.53.2.53-58. J Am Coll Health. 2004. PMID: 15495880 Review. No abstract available.
230 results